Press release
Nuclear Medicine/Radiopharmaceuticals Market : The Development Strategies Adopted By Major Key Players And To Understand The Competitive Scenario
Market Values:The Nuclear Medicine/Radiopharmaceuticals Market was worth US $5.55 billion in 2022, with a CAGR of 9%.
By 2029, the market is expected to reach US $10.14 billion.
To Know More About The Report :https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/
Report Scope: The report offers a detailed analysis of the Global Nuclear Medicine/Radiopharmaceuticals Market, including market drivers, restraints, opportunities, and challenges. It encompasses market segmentation by type, procedural volume, application, and geography. Key highlights include assessment of market dynamics, competitive outlook, and strategic business planning insights.
Research Methodology: The research methodology involves triangulation of data points from various sources and feeding them into a simulation model. Data points are obtained from paid and unpaid sources, along with paid primary interviews with key opinion leaders (KOLs). The report includes comprehensive analysis and forecast for five major geographies: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
To know about the Research Methodology :https://www.maximizemarketresearch.com/request-sample/7741
Drivers:
Increasing incidence and prevalence of cancer and cardiac ailments.
Growing adoption of modern treatments and diagnostic procedures.
Raising awareness regarding the advantages of radiopharmaceuticals.
Restraints:
High cost of nuclear medicine equipment.
Regional Insights:
North America expected to dominate the market, followed by Europe and APAC.
Well-established healthcare industry and rising awareness contribute to market growth in North America.
Presence of extensive usage of SPECT radioisotopes for diagnosis drives market growth in APAC.
Key Highlights:
Assessment of market definition, key players, and competitive outlook.
Comprehensive quantitative analysis from 2017 to 2024.
In-depth analysis of market segments, dynamics, and competition.
Detailed segmentation by type, procedural volume, application, and geography.
Forecast for five major geographies and their key regions.
To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741
Segmentation:
by Procedures
Cardiovascular
Oncology
Central Nervous System
Skeletal
Endocrine
Gastrointestinal
Pulmonary
by Type
Therapeutic
Alpha Emitters
Beta Emitters
Brachytherapy Isotopes
Diagnostic
PET Radiopharmaceuticals
SPECT Radiopharmaceuticals
by Application
Cardiology
Oncology
Thyroid
Neurology
Others
by End-User
Research Institutes
Hospitals
Diagnostic Centers
Others
Key Players
1. Advanced Accelerator Applications S.A.
2. Iba Molecular
3. Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
4. Eczacibasi-Monrol Nuclear Products
5. Siemens Healthcare
6. Sigma Aldrich Corporation
7. Bracco Imaging S.P.A
8. Bayer AG
9. Jubilant Pharma
10.Nordien, Inc.
11.Lantheus Medical Imaging, Inc.
12.GE Healthcare (A Fully-Owned Subsidiary of General Electric Company)
13.Mallinckrodt PLC
14.Cardinal Health, Inc.
15.Medtronic Plc.
16.Norgine B. V.
17.Curium
18.Eckert & Ziegler
19.NTP Radioisotopes
To access more comprehensive information, click here:https://www.maximizemarketresearch.com/request-sample/7741
Key Target Audience:
Research and Consulting Firms, Venture capitalists, private equity firms, and startup companies.
Radiopharmaceutical/Radioisotope Manufacturers and Distributors.
Healthcare Institutions, Contract Manufacturing Organizations (CMOs), Contract research organizations (CROs), and Government Bodies.
Market Scope: The report covers market segmentation by procedures, type, application, end-user, and geography. Key players include Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.
Frequently Asked Questions:
Growth rate of Global Nuclear Medicine/Radiopharmaceuticals Market: CAGR of 9% during the forecast period 2023-2029.
Segments covered: Type, process, application, end-user, and region.
Key players: Advanced Accelerator Applications S.A., Iba Molecular, Nordion, Inc., Siemens Healthcare, Sigma Aldrich Corporation, and others.
Study period: 2022 to 2029.
Our Top Trending Reports
India Steam Boiler Systems Market https://www.maximizemarketresearch.com/market-report/india-steam-boiler-systems-market/46997/
Global Alzheimer's Therapeutics Market https://www.maximizemarketresearch.com/market-report/alzheimers-therapeutics-market/164747/
Aesthetic Medical Devices Market https://www.maximizemarketresearch.com/market-report/aesthetic-medical-devices-market/169746/
Hybrid Heat Pump Market https://www.maximizemarketresearch.com/market-report/hybrid-heat-pump-market/147438/
North America Battery Energy Storage System Market https://www.maximizemarketresearch.com/market-report/north-america-battery-energy-storage-system-market/6744/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nuclear Medicine/Radiopharmaceuticals Market : The Development Strategies Adopted By Major Key Players And To Understand The Competitive Scenario here
News-ID: 3374962 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

What Is Driving the Growth of the Global Automotive Steering Wheel Market?
The Global Automotive Steering Wheel Market is projected to grow from USD 4.9 billion in 2023 to USD 7.1 billion by 2030, registering a CAGR of 5.5% during the forecast period. The increasing focus on driver safety, integration of steering-mounted electronics, and the rapid adoption of electric and autonomous vehicles are key drivers shaping market growth.
Asia Pacific remains the dominant region in terms of demand and production due to the…

United States Display Driver IC Market Trends Shift Toward Automotive Integratio …
The Global Display Driver IC Market is projected to grow at a robust CAGR of 7.2% during the forecast period, reaching an estimated market size of USD 11.3 billion by 2030, up from USD 6.9 billion in 2023. This growth is fueled by rising demand for OLED, flexible, and high-refresh-rate displays across applications in smartphones, smartwatches, automotive displays, and consumer electronics.
The Asia Pacific region leads the market in terms of…

Passive Optical LAN (POL) Market Projected to Reach USD 352.53 Billion by 2032
The global Passive Optical LAN (POL) Market is poised for significant growth, with projections estimating its value to reach approximately USD 352.53 billion by 2032. This expansion reflects a robust compound annual growth rate (CAGR) of 23.10% from 2025 to 2032.
Market Estimation & Definition
Passive Optical LAN (POL) is a fiber-based networking technology that utilizes passive optical components to deliver high-speed data, voice, and video services over a single strand of…

Optocouplers Market Set to Reach USD 7.26 Billion by 2030, Driven by Industrial …
The global Optocouplers Market is projected to grow significantly, reaching nearly USD 7.26 billion by 2030, with a compound annual growth rate (CAGR) of 8.5% during the forecast period. This growth is fueled by increasing demand across industrial automation, electric vehicles (EVs), and telecommunications sectors.
Market Estimation & Definition
Optocouplers, also known as opto-isolators, are semiconductor devices that transfer electrical signals between two isolated circuits using light. They are essential for ensuring…
More Releases for Radiopharmaceuticals
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029
The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029.
Gets a Sample Copy of the Nuclear…
Diagnostic Radiopharmaceuticals Market 2021 | Detailed Report
According to Market Study Report, Diagnostic Radiopharmaceuticals Market provides a comprehensive analysis of the Diagnostic Radiopharmaceuticals Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of Diagnostic Radiopharmaceuticals Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4645020
The report provides a comprehensive analysis of…
Global Radiopharmaceuticals Market 2017-2021
About Radiopharmaceuticals
Radiopharmaceuticals are pharmaceutical drugs having radioactive properties. The drugs can be used for therapeutic and diagnostic purposes. It is made up of radioisotope that bonds to an organic molecule. The radiopharmaceuticals find large application in the medical field due to their intrinsic properties. The radiopharmaceutical market is expected to benefit from the growing demand from the cancer market. Cancer is one of the major segments having a huge demand…
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Global Radiopharmaceutical Market Overview
1.1 Current Market Scenario
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Global Radiopharmaceticals Clinical Pipeline Overview
2. Global Radiopharmaceuticals Market Dynamics
3. Radioisotopes Used in Radiopharmaceuticals
4. EMA Guidelines for Radiopharmaceuticals
4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
4.2 Toxicological & Pharmacological Tests
4.3 Clinical Documentation
4.4 Radiation…
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use…
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a…